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Background: Appropriate patient information materials may support the consumer’s decision to attend or not to
attend colorectal cancer (CRC) screening tests (fecal occult blood test and screening colonoscopy). The aim of this
study was to develop a list of criteria to assess whether written health information materials on CRC screening
provide balanced, unbiased, quantified, understandable, and evidence-based health information (EBHI) about CRC
and CRC screening.
Methods: The list of criteria was developed based on recommendations and assessment tools for health
information in the following steps: (1) Systematic literature search in 13 electronic databases (search period: 2000–
2010) and completed by an Internet search (2) Extraction of identified criteria (3) Grouping of criteria into categories
and domains (4) Compilation of a manual of adequate answers derived from systematic reviews and S3 guidelines
(5) Review by external experts (6) Modification (7) Final discussion with external experts.
Results: Thirty-one publications on health information tools and recommendations were identified. The final list of
criteria includes a total of 230 single criteria in three generic domains (formal issues, presentation and
understandability, and neutrality and balance) and one CRC-specific domain. A multi-dimensional rating approach
was used whenever appropriate (e.g., rating for the presence, correctness, presentation and level of evidence of
information). Free text input was allowed to ensure the transparency of assessment. The answer manual proved to
be essential to the rating process. Quantitative analyses can be made depending on the level and dimensions of
criteria.
Conclusions: This comprehensive list of criteria clearly has a wider range of evaluation than previous assessment
tools. It is not intended as a final quality assessment tool, but as a first step toward thorough evaluation of specific
information materials for their adherence to EBHI requirements. This criteria list may also be used to revise leaflets
and to develop evidence-based health information on CRC screening. After adjustment for different procedure-
specific criteria, the list of criteria can also be applied to other cancer screening procedures.
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Since the 70s, cancer screening procedures have gained
increasing significance for public health and are promoted
in many countries. However, in recent years, it became
clear that the communication of some procedures may
have overemphasized their benefits and disregarded their
risks [1]. Potential harms of cancer screening include
adverse effects from the procedure itself, overdiagnosis,
and false-positive results, including the mental stress and/
or unnecessary diagnostic tests resulting there from [2].
For this reason and for ethical reasons that apply to all
medical procedures with potential side effects, participants
must give their informed consent before screening [3,4].
In Germany, persons aged 50 and older who have statu-
tory health insurance have free access to colorectal cancer
(CRC) screening tests, including the fecal occult blood test
(FOBT) and (since 2002) screening colonoscopy. As col-
onoscopy is an invasive and burdensome procedure with
potentially lethal complications (very rare) [5,6], special
efforts are needed to ensure informed decision-making [3].
Like other health communication strategies, written
health information materials support informed choices
regarding whether or not to attend CRC screening and
have certain tests performed [7,8]. Appropriate information
should meet evidence-based health information (EBHI)
standards [9]. Accordingly, it must include balanced,
unbiased, quantified, understandable, and evidence-based
information about CRC and the potential benefits and
harms of the screening procedures [10]. Numerous tools
to evaluate the quality of health-related information are
available. However, we found no tool or checklist that sys-
tematically evaluates health information on cancer screen-
ing procedures according to EBHI standards. The existing
tools focus on criteria for the characterization of structural
and process quality (e.g., DISCERN [11]), self-assessment
of lay persons (e.g., Check-In [12]), or a reviewer’s subject-
ive judgment of specific benefits and harms [13]. Collected
information about structural and process quality is typic-
ally used as a surrogate marker for parameters of outcome
quality. For example, editorial independence stands for
balanced information or clarity, and layout for under-
standability. None of the generic tools, including the Inter-
national Patient Decision Aid Standards Instrument
(IPDASi) [14], directly evaluates reliability and under-
standability – two important features of EBHI. Thus, false
or biased information may be rated as appropriate just
because formal standards are met.
In Germany, many different players in healthcare provide
information about CRC screening. These include govern-
mental organizations, foundations, healthcare providers,
and health insurance companies. Presumably, not all of
the existing information meets EBHI standards, but rather
depicts only the benefits without harms and/or strongly
encourages participation in screening [15]. The GermanNational Cancer Plan [16] was initiated by the Federal
Ministry of Health in 2008 to develop and improve cancer
screening and care of cancer patients. One aim is to en-
hance consumer information materials on the benefits
and risks of screening procedures to support informed
decision-making regarding whether to attend screening or
not. In this context, the Federal Ministry of Health initi-
ated a project on CRC screening to identify consumer
education materials in conformity with EBHI standards.
Initially, we developed a list of criteria that helps experts
systematically assess whether the available flyers and
brochures provide reliable, correct, understandable and
unbiased information on CRC screening. The underlying
concepts and methods of the development process as well
as the resulting list of criteria and its strengths and weak-
nesses are presented in this article. Rating examples are
provided to illustrate the application of this instrument.
Methods
Study design
The whole research project included steps 1) to identify
consumer education materials on CRC 2) to develop an
assessment tool for experts’ use 3) to assess the identi-
fied materials from experts’ view, and 4) to assess the
materials from consumers’ view. The study protocol was
approved by the ethics committee of Hannover Medical
School (Application No. 1803–2013). In this article we
focus on the development of the assessment tool.
The main goal was to produce a comprehensive list of
criteria based on EBHI requirements for detailed assess-
ment of the contents and correctness of health informa-
tion on CRC screening and to make such assessments as
objective as possible. Criteria were extracted from rec-
ommendations on EBHI and supplemented with criteria
from previous health information assessment tools. The
extracted criteria were sorted and categories and subcat-
egories were defined. The list of criteria was developed
in the following steps (Figure 1):
(1)Systematic literature search to identify
recommendations and assessment tools for health
information
(2)Extraction of the identified criteria
(3)Grouping of the criteria into categories and a
comprehensive list of criteria
(4)Review of the list of criteria by external experts
(5)Modification of the list of criteria
(6)Creation of an answer manual
(7)Discussion with external experts
These steps are described in detail in the following sec-
tions. As shown in Figure 1, we also rated German flyers
and brochures on CRC screening with the developed list
of criteria. The results are not shown, but rating examples
Development of the list of criteria
Presentation and discussion
with the external experts panel
Systematic literature research 
for tools and recommendations
for (creating) health information
Review of 
external experts 
Search for evidence 
in guidelines, HTA-Reports,
systematic reviews
Compilation of the 
list of criteria
Extraction of the criteria
Grouping the criteria
Extraction of evidence
Assessment of information material






Final list and manual
Compilation of the 
manual
Development of the answer manual
Figure 1 Study design used to develop the list of criteria and answer manual.
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to apply the instrument.
Methodological considerations
The derived a priori methodological considerations for
the list of criteria were as follows:
(1) Criteria will not ask for aggregated information, if
possible. For example, instead of asking for “any”
adverse effects, it will ask in detail about single
adverse effects like bleeding, pain, and perforation
in order to prevent the reviewer from assessing
combined information.
(2) If possible, there will be no multi-level response
options (e.g., Likert items), but rather “yes”, “no” or
“unclear”. Rationale: The goal is not to obtain levels
of agreement or disagreement, as with
psychometric tools, but unambiguous statements.
(3) The direction of the response options shall be
adjusted in such a way that “yes” always
corresponds to a rating of “adequate” or
“appropriate”.(4) No numerical rating or sum score will be used (no
use of scales yielding a summary score). Rationale:
Summary scores imply an implicit weighting of the
criteria that is not evidence-based but arbitrary.
(5) Except for formal issues (specification of authors,
publication date, etc.), each reviewer shall not only
document whether specific information was
reported but also whether it was correct, (e.g.,
whether the risk of bleeding was reported, and
whether it was reported correctly).
(6) Reporting about evidence levels or non-sufficient
evidence will be recorded.
(7) Each rating will be accompanied by the
corresponding quotation from the information
source to ensure the transparency of assessment.
(8) A detailed, evidence-based answer manual will be
developed and implemented in order to achieve
consistent ratings.
(9) Assessment of the information material will be
carried out by two independent reviewers, and any
discrepancies will be resolved by consensus with a
third reviewer.
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A comprehensive systematic literature search was car-
ried out in 13 electronic databases, including EMBASE
and Medline. The search included health information
recommendations and assessment tools for information
on the underlying disease. It was restricted to articles in
English or German published from 1/2000 to 8/2010. The
search strategy involved the following keyword combina-
tions and their German translations: “criteria”, “quality”,
“quality criteria”, “checklist”, “evaluation” or “assessment”
combined with the terms ”decision support for patient-
informed decision-making”, “patient information”, “shared
decision/decision making”, “risk communication”, “health
information”, “evidence-based patient information” and
“information brochures”. This search yield a total of 3,097
documents that were stepwise selected on the level of title,
abstract and full text. A manual search was carried out
based on the references in the identified publications.
Additionally, a web-based search was performed with the
Google search engine using combinations of keywords
similar to those used in the database research. The first 50
results of each of the 19 search terms were evaluated for
appropriateness. The detailed strategy used for the data-
base search and the web-based search is listed in the Ap-
pendix (see Additional file 1). Two independent reviewers
screened and selected the articles.
Extraction and categorization of criteria
From the identified documents, two researchers (MD,
BB) extracted and grouped criteria on formal issues,
CRC, CRC screening procedures, neutrality and balance,
while two others (GS, IK) extracted criteria on presentation
and understandability. The resulting list of criteria was ap-
proved by the whole project team. These researchers also
applied the list of criteria in step 3 of this project that is
not within the scope of this article.
Answer manual
A manual providing the correct answers for each criter-
ion was developed. The aim was to minimize the sub-
jectivity of ratings and achieve clear and unambiguous
assessments. Whenever possible, the correct answers
were derived from selective literature searches focusing
on evidence from systematic reviews, HTA reports or
S3 guidelines. Evidence levels were assigned according
to the Oxford Centre of Evidence-based Medicine [17].
Review by external experts
Twelve external experts in the field of (colorectal) cancer
screening, including patient representatives and staff
from governmental health-related institutions, cancer
research institutes, providers of healthcare services, and
statutory health insurances were asked to review the
preliminary list of criteria. Six experts responded,providing feedback in a telephone interview with two
researchers. Their comments were recorded instantly.
Modifications proposed by the experts were discussed
within the project team and, if approved, implemented
into the list of criteria. The final list of criteria was
discussed in a meeting with the experts.Results
Development of the list of criteria
Fifteen documents with recommendations and 16 with
assessment tools for health information were identified.
Among the recommendations, n = 2 referred to cancer
screening [16,18], n = 1 to screening [19], and n = 1 to
orthopedic interventions [20]; n = 11 had no special focus
[4,9,21-29]. Among the assessment tools, n = 1 referred to
colorectal cancer screening [15], n = 1 to diagnostic breast
tests [30], n = 3 refer to mammography screening [31-33],
and n = 2 to patient decision aids [14,34], and n = 7 had no
special focus [11,12,35-41]. Criteria for assessing health
information were systematically extracted from these
documents, and the single criteria were grouped into
seven categories (Table 1): formal issues, information
on CRC screening, information on screening colonoscopy,
information on the fecal occult blood test, readability/
comprehensibility, layout and neutrality and balance.
These categories were further aggregated into four do-
mains, one representing CRC-specific content issues
and three describing generic issues applicable to differ-
ent cancer screening procedures.
The preliminary list of criteria was modified in re-
sponse to the experts’ reviews, mainly by including
additional criteria (e.g. inability to drive after
sedation, further risks in the preparation phase of
colonoscopy, possibility of being unable to work on
the day of examination, and the need to sign a
consent form and give a blood sample before the
examination).Final list of criteria
The final list of criteria contains 230 criteria
(Table 1). Most of the single criteria are rated multi-
dimensionally: reporting: yes/no; correctness: yes/no/
unclear; presentation: text, numbers, diagrams, tables
and/or images; level of evidence: yes, no, lack of evi-
dence indicated (Table 2). To enhance the rating
transparency of each criterion, space for free text is
provided for verbatim quotes or reported numbers,
to document whether a number was presented as a
natural frequency [42,43], and to specify whether a
denominator was included, etc.
Elements of the four domains are explained in de-
tail below, including assessment examples, where
appropriate.
Table 1 Content structure of the list of criteria for evaluating consumer information materials on colorectal cancer
(CRC) screening (n = 230 criteria*)
Domain (n criteria) Category (n criteria) Subtopic (n criteria) Dimensions to rate
Specific A. Content issues (130) Information on CRC and
CRC screening (32)
CRC screening (12) Reported: yes / no
Aetiology and epidemiology of
colorectal cancer (German data) (20)
Correct: yes / no / unclear
Presentation format: text / number /
chart / Table / figure
Evidence level reported: yes / no /
lack of evidence indicated
Inclusion of quotes / notes
Information on screening
colonoscopy (66)
Colonoscopy preparation (7) Reported: yes / no
Colonoscopy sedation (4) Correct: yes / no / unclear
Procedure (13) Presentation format: text / number /
chart / Table / figure
Test characteristics (7)
Conduct in response to test results (3) Evidence level reported: yes / no /
lack of evidence indicated
Benefit (disease-specific incidence and
total mortality) (9) Inclusion of quotes / notes
Risks and adverse effects including
overdiagnosis (23)
Information on FOBT (32) Procedure (9) Reported: yes / no
Test characteristics (8) Correct: yes / no / unclear
Conduct in response to test results (3) Presentation format: text / number /
chart / Table / figure
Benefit (disease-specific incidence and
total mortality) (9) Evidence level reported: yes / no /
indication of lack of evidence
Risks and adverse effects including
overdiagnosis (3) Inclusion of quotes / notes
Generic B. Formal issues (33) Formal issues (33) Author and stakeholders involved (14) Reported: yes / no
Editorial independence (6) Inclusion of quotes / notes
Sources and currentness of data (8)





Language (18) Present: yes / mostly yes / mostly no
/ no / not applicable
Sentences (4)
Content structure (3) Inclusion of quotes / notes
Numerical data (4)
Layout (30) Structure (11) Present: yes / mostly yes / mostly no
/ no / not applicable
Writing/font (6)






Calls for participation (1) Present: yes / no / unclear
Fear / downplay (4) Inclusion of quotes / notes
Uneven presentation of procedures (2)
The bold subtopics are presented in detail in Tables 2–5. The criteria of Domain D are listed in the text.
*One comprehensive criterion on the correctness of the information is not shown.
FOBT: fecal occult blood test.
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Domain A includes three categories (see Table 1). The
subtopic “Information on the etiology and epidemiology
of CRC” of the category “Information on CRC and CRC
screening” is presented in Table 3 to elucidate theprocedure for detection of epidemiological frequencies.
It becomes clear that not all criteria have to be met for
information material to qualify as being of high quality.
Examples of how information in flyers and brochures of
this category were assessed are shown below.
Table 3 Criteria for the aetiology and epidemiology of
CRC (n = 20) (Domain A, Category: Information on CRC
and CRC screening)
1 Meaning of premalignant conditions like polyps is stated.
2 Frequency of polyps/adenomas is stated.
3 Risk factors are stated.
4 Protective measures are stated.
5 Incidence is stated.
6 Sex-specific incidence is stated.
7 Age-specific incidence (age-stratified incidence) is stated.
8 Mortality is stated.
9 Sex-specific mortality is stated.
10 Age-specific mortality is stated.
11 Residual lifetime disease risk is stated.
12 Residual lifetime risk of death is stated.
13 Age-specific disease risk within a given time interval is stated.
14 Age-specific mortality risk within a given time interval is stated.
15 The disease risk compared to other cancer disease risks is stated.
16 The disease risk compared to other risks is stated.
17 The mortality risk compared to other cancer mortality risks is stated.
18 The mortality risk compared to other risks of death is stated.
19 The natural course of CRC is stated.
20 Incidence and mortality are not stated in one sentence.
Table 2 Dimensions of the list of criteria (excerpt)
Risks and adverse effects of screening colonoscopy
Criterion Reported? Correct? Presentation? Evidence level reported? Quotes / notes
Overall risk of adverse effects of screening
colonoscopy is indicated
□ yes □ yes □ text □ yes
□ no □ no □ number □ no
□ unclear □ chart □ lack of evidence indicated
□ table
□ image
Risk of pain is indicated □ yes □ yes □ text □ yes
□ no □ no □ number □ no
□ unclear □ chart □ lack of evidence indicated
□ table
□ image
Risk of cardiovascular symptoms is indicated □ yes □ yes □ text □ yes
□ no □ no □ number □ no
□ unclear □ chart □ lack of evidence indicated
□ table
□ image
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cancer in both men and women.”
This statement would be rated as criterion 15 (Table 3):
– Reported? “Yes”
– Correct? “Yes”
– How presented: “Text” (not “Number”)
– Evidence level reported? “Not applicable”
– Quotes: Citation
Example 2: “22,000 people die each year from CRC.”
This statement would be rated as criterion 8 (Table 3):
– Reported? “Yes”
– Correct? “No” (number is too low for Germany)
– How presented: “Number”
– Evidence level reported? “No”
– Quotes: “Denominator is lacking, outdated number”
Both examples show the importance of having a man-
ual that provides the correct answers and numbers and,
in the second case that defines what extent of deviation
from the actual number is acceptable as “correct”.
Therefore, the manual is a core part of the list of
criteria.
The categories of the two screening procedures, fecal
occult blood test and colonoscopy, are constructed simi-
larly. They begin with information on the procedure itself
and are supplemented by further criteria on colonoscopy
preparation and sedation. Both procedures incorporate
criteria on test characteristics (such as sensitivity, speci-
ficity, predictive value), on conduct in response to test
Table 4 Criteria on benefits (n = 9) and risks (n = 23) of
screening colonoscopy (Domain A, Category: Information
on screening colonoscopy)
Benefits of screening colonoscopy
Outcome: CRC incidence
1 Absolute risk reduction is stated.
2 Relative risk reduction is stated.
3 Number needed to screen is stated.
Outcome: CRC mortality
4 Absolute risk reduction is stated.
5 Relative risk reduction is stated.
6 Number needed to screen is stated.
Outcome: All cause mortality
7 Absolute risk reduction is stated.
8 Relative risk reduction is stated.
9 Number needed to screen is stated.
Risks of screening colonoscopy
Preparation
1 Common risk of side effects is stated.
2 Risk of cardiovascular symptoms is stated.
3 Risk of nausea is stated.
4 Risk of allergies is stated.
5 Risk of cramps is stated.
6 Risk of pain is stated.
Sedation
7 Common risk of side effects is stated.
8 Risk of respiratory distress/failure is stated.
9 Risk of cardiovascular symptoms is stated.
10 Risk of Nausea is stated.
Procedure itself
11 Common risk of side effects is stated.
12 Number needed to harm is stated.
13 Risk of pain is stated.
14 Risk of cardiovascular symptoms is stated.
15 Risk of Nausea is stated.
16 Risk of bleeding is stated.
17 Risk of infection is stated.
18 Risk of perforation is stated.
19 Risk of mortality is stated.
Overdiagnosis
20 Risk of overdiagnosis/overtreatment is stated.
21 Frequency of overdiagnosis is stated.
23 Consequences of overdiagnosis are stated.
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cluding overdiagnosis.
Table 4 shows the criteria on the subtopics of benefits
and risks of screening colonoscopy. Benefits include three
relevant outcomes: CRC incidence, CRC mortality and all-
cause mortality. Each outcome is divided into absolute and
relative risk reduction and the number needed to screen.
Risk criteria for screening colonoscopy are divided into
risks during colonoscopy preparation (including colon
cleansing), risks related to adverse effects of sedative drugs,
risks of the procedure itself, and risks of overdiagnosis. The
subject of overdiagnosis is included because it is known to
occur in cancer screening to a varying extent depending on
the type of cancer [44-46]. Nevertheless, the extent of over-
diagnosis or overtreatment of harmless polyps that would
never turn into cancer in colorectal cancer screening is un-
known and may be low as there are strong hints that colon-
oscopy will decrease CRC incidence like it is already shown
for flexible sigmoidoscopy-based screening [47]. The rating
procedure for benefits and risks is illustrated below.
Example 3: “According to experts, more than three-
quarters of CRC patients could be saved by early screening
colonoscopy.”
This statement would be rated as criterion 5, CRC
mortality (Table 4: Benefits):
– Reported? “Yes”
– Correct? “Yes”
– Presented as: “Number”
– Evidence level reported? “Yes”
– Quotes: “No natural frequency, denominator is
lacking, no absolute risk reduction is given,
evidence from level 3 (case-control) studies is
falsely presented as experts’ evidence”.
Example 4: “80% of all CRCs can be prevented by
screening colonoscopy.”
This statement would be rated as criterion 2, CRC in-
cidence (Table 4: Benefits):
– Reported? “Yes”
– Correct? “Yes”
– Presented as: “Number”
– Evidence level reported? “No”
– Quotes: “No natural frequency, denominator is
lacking, no absolute risk reduction is given, evidence
from level 3 (case–control) studies
Example 5: “… is a harmless drug preparation”
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– Evidence level reported? “No”
– Quotes: Citation
Example 6: “… no pain”




– Presented as “Text”
– Evidence level reported? “No”
– Quotes: CitationDomain B: formal issues (generic)
This domain assesses the formal characteristics of infor-
mation materials, including information on the authors
and editors, possible conflicts of interest, publication
dates, aims and target groups. Due to the nature of this
meta-information, only the presence or absence of these
criteria is rated and not their correctness. As criteria in
this domain are very are widely used, we do without de-
scribing them in detail.Domain C: presentation and understandability (generic)
“Understandability (readability/comprehensibility)” as-
sesses the language, sentences, content structure, and
numbers of information materials, whereas “presentation
(layout)” concerns the structure, font, visual elements
and design of the materials (see Table 1). These criteria
(e.g., “Sentences are of appropriate length”) require more
detailed rating, such as that achieved by four response
categories. Therefore, all criteria in this domain were
rated on a four-point-scale (yes / mostly yes / mostly no
/ no). Furthermore, it makes no sense to rate the cor-
rectness of these criteria. For most of the assessments in




1 There is one message per sentence. 1
2 Sentences are of appropriate length. 2
3 Complex sentences are avoided. 3
4 Identical repetitions are avoided. 4
Numerical data 5
1 Natural frequencies are used. 6
2 Reference parameters are given. 7
3 Same denominators are used. 8
4 Loss and gain framing is balanced. 9example, when assessing the length of a sentence, the as-
sessor must search the entire health information mater-
ial for sentences that are too long. To ensure an
unambiguous assessment, the manual should provide a
definition of what is “too long” and what proportions of
run-on long sentences should lead to which specific
ratings. Table 5 provides a detailed list of criteria for
sentences, numbers and visual elements followed by a
rating example for this category.
Example 7: “every year 70,000 persons are newly diag-
nosed with colorectal cancer.”
Provided that this is the only number given in the
health information, this statement would be rated as
follows:
– Numerical data criterion 1: Natural frequencies are
used? “Yes”
– Criterion 2: Reference parameters are given? “No”
– Criterion 3: Same denominators are used? “No”
– Criterion 4: Loss and gain framing is balanced? “No”
Usually, several numbers are stated in a text. In that
case, an aggregated assessment is required.
Domain D: neutrality and balance (generic)
The last domain comprises seven criteria for assessment










V1 “Is free of persuasive language”
2 “Is free of scare language”
3 “Is free of scary pictures or graphs”
4 “Is free of fear appeals”
5 “Is free of downplay or minimization”
6 “Is free of one-sided presentation of benefits without
risks”
7 “Is free of unbalanced presentation of screening
procedures”visual elements (n = 9) (Domain C, sub topics from
isual elements
isual elements are included.
rawings are used instead of photos.
isual elements are explained in the text.
he explanatory text is near the visual element.
he visual element is not surrounded by text.
isual elements are clearly labeled.
iased scaling is avoided.
mportant spots of the visual element are marked by arrows, circles etc.
isual elements include a legend.
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scary or down-playing language is used to increase partici-
pation in screening. We initially defined these criteria as
“Does not contain….”, but this phrase was abandoned be-
cause the possible double-negative reply might be confus-
ing. The last two criteria combine benefits and risks and
presentation of the procedures. To handle this aggregate
information, careful operationalization within the manual
is needed. Rating examples for this category are given
below.
Example 8: “… should participate in bowel cancer
screening.”
This statement would be rated as criterion 1:
Met? “Yes”.
Example 9: “… is a wicked disease”
This statement would be rated as criterion 2:
Met? “Yes”Applications / practicability
For trained reviewers, the assessment takes about
15–30 minutes for flyers and 15–45 minutes for bro-
chures. Documentation of the corresponding cita-
tions took up much of the time. Although this
approach may be time-consuming, it may hasten
consensus and, most importantly, ensures the trans-
parency of quality assessment.
Inter-rater reliability was not evaluated because the
final assessment was achieved by consensus in each
case. Discrepant findings were mainly caused by
overlooked aspects. Consensus usually took 5 to 15 minutes.




Common risks are stated
Risk of pain is stated
Risk of cardiovascular symptoms is stated
Risk of nausea is stated
Risk of bleeding is stated
Risk of infections is stated
Risk of perforation is stated 
Risk of death is stated
Problem of overdiagnosis is stated
Frequency of overdiagnosis is stated
Possible consequences of overdiagnosis are 
stated




Figure 2 Presentation of exemplary rating results of risks and adversPossible methods of presenting rating results
Quantitative analyses can be made on the level of criteria
and their dimensions. Until now, none were performed on
the level of subtopics, categories or domains. A method to
qualitatively sum up the single-criteria results is also lack-
ing. To obtain an overview, the combined results of the
two dimensions “Reported?” and “Correct?” can be visual-
ized by means of a traffic light system, using green (cor-
rectly reported), yellow (reported but unclear), red
(incorrectly reported), and white (not reported) marks.
Figure 2 gives an example from the category “Risks and
adverse effects of screening colonoscopy” as presented in
brochures. This (traffic light) presentation provides a com-
prehensive overview of results for each criterion (rows),
each type of education material (columns), and differ-
ences between materials as in benchmarking procedures.
It clearly shows that information on risks is rather limited
and sometimes false, and that three brochures contain no
information on risks.Discussion
High-quality patient information materials may help con-
sumers make informed decisions for or against participa-
tion in CRC screening. For identification of appropriate
information materials, we compiled a list of criteria via
qualitative aggregation based on systematically identified
recommendations and tools, and validated the list of
criteria by a review process. This instrument is designed
for use by persons with expertise in cancer screening. It
explicitly is not a checklist for consumers to check the
quality of health information. The final manual-based list
of criteria contains 230 criteria in four domains. TheC D E F G H I J K L M
e effects of screening colonoscopy in 13 brochures (11 criteria).
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and correctness of information), if applicable. Free text
entries (mainly verbatim quotes) were allowed to ensure
rating transparency.
One main limitation of the list of criteria is the lack of
a summary assessment. It may be tempting to use a
numerical scoring system for simplicity, but there is no
empirical evidence to support this. Consequently, as
there is no justification for a scoring system that applies
an arbitrary (one point per criterion, etc.) or explicit
weighting system, we rejected the use of a numerical
scoring system or scale. Scales for quantitative assess-
ment of study quality were very popular until empirical
evidence [48] and theoretical considerations [49] indi-
cated that scales provide invalid results. Because of the
lack of a summary assessment method, analyses with the
proposed list of criteria are restricted to the level of sin-
gle criteria. This is inconvenient due to the large number
of criteria to be assessed. To give an overview of the re-
sults, we used a traffic light (status indicator) system.
This system can indicate two dimensions (e.g., presence
and correctness of information) simultaneously, and it
provides detailed information on single and overall cat-
egories. Such a comparative overview is particularly useful
for benchmarking purposes. The future aim is to develop
a qualitative summary assessment based on ratings on the
category level. A Delphi consensus process might be used
to explore the importance of each criterion, as was done
in International Patient Decision Aids Standard Instru-
ment (IPDASi) development [14].
The list of criteria represents the maximum content of
information material. Not all of the criteria are essential
for high-quality information. The comprehensiveness
and depth of information materials vary depending on
the targets and target groups. Thus, it would be reasonable
to differentially define essential criteria for short informa-
tion materials like flyers and for more detailed materials
like brochures. It would also be reasonable to select these
mandatory, material-specific criteria in a Delphi procedure
including experts and consumers. Obviously, expert and
consumer opinion is needed to explore the importance of
each criterion for further summary assessments and to
develop specific assessment lists of criteria for short and
more detailed information materials. This input could be
used in further research to revise the list of criteria.
The rationale behind providing EBHI on cancer
screening is to enable consumers to make informed
choices for or against cancer screening. The proposed
list of criteria examines whether health information ma-
terials meet EBHI standards. It cannot directly assess
whether the information is suitable to support informed
decision-making. There is evidence from two random-
ized controlled trials that decision aids on CRC screen-
ing via FOBT [8] and FOBT/colonoscopy [7] mayeffectively support informed choice. However, both
studies compared an interactive decision booklet with
an accompanying DVD [8] or interactive internet mod-
ule [7] (intervention groups) against a standard govern-
mental booklet (control group). The effect may have
been mediated by the interactive components resulting
in more intense study of the materials. The proposed list
of criteria does not assess interactive components. Ul-
timately, if information materials are found to meet
EBHI standards according to our list of criteria, it can-
not be concluded that these materials promote informed
choice. Such a claim would have to be verified in further
studies.
The ethical goal of EBHI to enable as many of the
target population to make an informed decision whether
or not to participate in CRC screening [3] may be
conflicting with the aim of achieving a high uptake [50].
There is inconclusive evidence on detailed information
material, it may have a positive or no effect on participa-
tion [7,10] or may even increase non-attendance [8].
Non-attendance based on an informed choice has to be
accepted, while non-attendance arising from the EBHI
itself and not from an informed choice is not desirable.
EBHI especially may deter socioeconomically disadvan-
taged people and those with low health literacy from
participating in screening [51] resulting in higher health
inequalities. Further research is needed to explore tailored
communication strategies for deprived target groups fo-
cusing on increasing knowledge and understanding to
promote an informed choice-making.
To our knowledge, the proposed list of criteria is the
first assessment tool designed to rate the correctness of
consumer education materials on CRC screening. Many
existing tools use structural quality as a surrogate for
content quality, which might not always be correct. For
example, it was shown that website origin does not
predict content quality: the quality of university websites
was not better than that of commercial websites [52].
Website certification programs like the HON (Health on
the Net) code [53] and MedCERTAIN (MedPICS Certifi-
cation and Rating of Trustworthy Health Information on
the Net) were also established to ensure the provision of
reliable information. The HON code requires health in-
formation website owners to abide by eight principles: to
indicate the authors’ qualifications, information sources,
funding sources and advertising policy and to maintain
confidentiality, etc. However, there are concerns that
these criteria might not be sufficient to identify trust-
worthy information. For example, the HON label failed
to predict the good content quality of mental health-
related websites in some cases [52]. In contrast, the DIS-
CERN score was shown to be a content quality indicator
of relatively high specificity [52,54]. Other analyses of
web-based information on depression found that content
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label [55]. However, the usual tools for the assessment of
content quality do not check the correctness of informa-
tion and might even rate false information as being of
good quality.
As the proposed manual provides the correct answers
to the criteria queries, it is an essential part of the rating
method. Ideally, many CRC-specific content criteria
should be explored by systematic reviews, especially if
related to benefits and risks. This was not feasible in this
project. Our research, which was mainly restricted to se-
lectively searched evidence from S3 guidelines, systematic
reviews and HTA reports, was still very time-consuming.
It will be challenging to incorporate the latest evidence in
the finished manual, as knowledge changes over time. It is
also unclear how often the manual should be updated.
Other problems can arise from different interpretations of
the evidence. In breast cancer screening, for example, ex-
perts disagree on the actual numbers characterizing the
benefits and risks in a British leaflet [56]. The National
Cancer Institute (USA) took an interesting approach to
providing key information, namely, by posting a one-page
factsheet on lung cancer screening for doctors and pa-
tients providing numbers on benefits and risks derived
from a randomized controlled trial [57]. In Europe, aggre-
gated uniform evidence-based factsheets on screening
procedures would complement the existing comprehen-
sive guidelines [3] and would offer a thorough base of
knowledge for different players who provide information
on cancer screening.
Conclusions
The range of the proposed evaluation concept based on
a list of 230 criteria and answer manual goes beyond
that of previous instruments for quality assessment of
health information in that it considers not only the pres-
ence, but also the correctness of health information. How-
ever, this comprehensive list of criteria is not intended as a
final quality assessment tool, but rather as a first step to-
ward thorough evaluation of specific information materials
for adherence to EBHI standards made by persons with
professional expertise in cancer screening. It may also be
used to revise existing leaflets or to develop health infor-
mation materials on colorectal cancer screening. Further-
more, the proposed list of criteria can be transferred to
other cancer screening procedures after suitable modifica-
tion of the procedure-specific criteria.
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